BACKED BY DIAGNOSTIC GREEN IC-Flow Benefits

Why Clinicians Choose IC-Flow

Developed by Diagnostic Green, the global supplier of Verdye™ (Indocyanine Green, ICG), the IC-Flow brings together deep ICG expertise and a practical understanding of clinical fluorescence imaging. The result is a dependable, easy-to-use and cost-effective system designed for adoption across a wide range of hospitals and surgical practices.

Benefit What it means for your team
Fast boot-up time Less waiting, more operating – ready when your case is ready
Simple, intuitive design Minimal training required, so any team member can operate it confidently
Flexible configurations Point of Care or full theatre system – match the set-up to your speciality
Wi-Fi enabled Supports image and video transfer if required – subject to your local IT and data management requirements and needs
Portable Point of Care option Supports use across suitable clinical settings within the device’s intended purpose
LED, not laser, light source Non-ionising LED illumination rather than a laser light source
Minimal maintenance & service Lower total cost of ownership over the life of the system
Most cost-effective NIR system on the market Bring fluorescence guidance to more cases, more often

OUTCOMES THAT MATTER

Better outcomes, reduced costs

Published studies of ICG fluorescence imaging in selected applications report potential clinical and economic benefits including:

BREAST RECONSTRUCTION SURGERY

26.5% 5%

In breast reconstruction surgery, clinical assessment alone showed a 26.5% complication rate versus 5% with laser-assisted ICG angiography.¹

MASTECTOMY SKIN FLAP NECROSIS

6.7% 0.9%

In mastectomy skin flap necrosis, clinical assessment alone showed a 6.7% rate (n=254) versus 0.9% (n=13) with laser-assisted ICG angiography (p=0.02).²

COST OF A SINGLE COMPLICATION

~$100,000

The average excess cost of a single case of flap necrosis in a US study was calculated at almost $100,000 per patient.³

Other studies have found that pairing ICG with a visualisation system like IC-Flow reduces failure rates, lowers healthcare costs, and improves overall patient outcomes.4 5 6

TESTIMONIAL

What surgeons say

“The cost benefit of the IC-Flow Imaging System is more than justified. This portable camera is easy to use and provides an efficient fluorescence image.”

– Prof Jaume Masia, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain

“User friendly, affordable and compact.”

– Dr Jorge Falco, University of Buenos Aires

More Economic Evidence

References

  1. Chatterjee et al. Plast Reconstr Surg. 2013;131(5):693e–701e.
  2. Harless et al. Breast J. 2016;22(3):274–81.
  3. Duggal CS. An Outcome Analysis of Intraoperative Angiography for Postmastectomy Breast Reconstruction. Aesthetic Surgery Journal. 2014;34(1):61–5.
  4. Hitier M, Cracowski JL, Hamou C, Righini C, Bettega G. Indocyanine green fluorescence angiography for free flap monitoring: a pilot study. J Craniomaxillofac Surg. 2016 Nov;44(11).
  5. Alstrup T, Christensen BO, Damsgaard TE. ICG angiography in immediate and delayed autologous breast reconstructions. J Plast Surg Hand Surg. 2018 Oct;52(5).
  6. Green JM, Thomas S, Sabino J, et al. Use of Intraoperative Fluorescent Angiography to Assess and Optimise Free Tissue Transfer in Head and Neck Reconstruction. J Oral Maxillofac Surg. 2013;71(8):1305–1480.